SCHEMBL8610628

SCHEMBL8610628

O=C1CCC(C(=O)N[C@H](CS)C(=O)O)N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 8/20 0.47
▸ HDAC11 Q96DB2 8/20 0.47
▸ HDAC6 Q9UBN7 8/20 0.47
▸ HDAC1 Q13547 7/20 0.47
▸ HDAC10 Q969S8 7/20 0.47
▸ HDAC8 Q9BY41 7/20 0.47
▸ HDAC2 Q92769 6/20 0.47
▸ TRHR P34981 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ THPO P40225 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ NCOR2 Q9Y618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9481069 1.00 HDAC3 (0.47) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL6433940 1.00 HDAC3 (0.47) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL6433938 1.00 HDAC3 (0.47) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL9504461 1.00 HDAC3 (0.47) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL8610625 1.00 HDAC3 (0.47) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL31199179 0.95 HDAC3 (0.47) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL29825005 0.87 SMN1; SMN2 (0.41) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL10661794 0.87 HDAC3 (0.43) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL31199135 0.86 ACE (0.43) HDAC3HDAC11HDAC6HDAC1HDAC10
SCHEMBL31672199 0.85 TRHR (0.42) HDAC3HDAC11HDAC6HDAC1HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0674653-B1 THERAPEUTIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES CONNECTED WITH GLUTATHIONE DEFICIENCY, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME PROSPA BV (NL) 1998-08-12 — — EP disclosed
US-5736565-A SULFUR-ACYLATED DERIVATIVES OF L-PYROGLUTAMYL-L-CYSTEINE; USEFUL FOR TREATMENT OF HEPATIC DISORDERS, INTOXICATION FROM DRUG OR CHEMICAL AGENTS, EXPOSURE TO XENOBIOTIC AGENTS, DAMAGE CAUSED BY RADIATION, BRAIN AGING, OR IMMUNE SYSTEM PROSPA B.V. (NL) 1998-04-07 — — US disclosed
Send feedback